View Older Stories View More Recent Stories

Apr 28, 2025 11:34AM HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
Apr 28, 2025 03:25AM HSBC Downgrades Biogen (BIIB) to Hold
Apr 22, 2025 05:14AM BTIG Reiterates Neutral Rating on Biogen (BIIB)
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 10:07AM Biogen (BIIB) PT Lowered to $134 at UBS
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 3, 2025 08:57AM Biogen (BIIB) PT Lowered to $221 at RBC Capital
Apr 2, 2025 07:30AM Biogen's (BIIB) Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
Apr 1, 2025 07:31AM Organon (OGN) Acquires TOFIDENCE
Mar 24, 2025 07:31AM Biogen (BIIB) Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
Mar 17, 2025 10:00AM These 11 stocks are Mizuho's Aging Intelligence (AI) top picks
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Feb 28, 2025 08:24AM Biogen (BIIB) and Eisai: CHMP Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Feb 18, 2025 04:04PM Oppenheimer Reiterates Outperform Rating on Biogen (BIIB)
Feb 18, 2025 08:03AM Biogen (BIIB) and Stoke Therapeutics (STOK) Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome
Feb 18, 2025 08:01AM Piper Sandler on Biogen (BIIB): 'Can Still Get Worse For The Shares'; PT Lowered to $135
Feb 18, 2025 06:19AM Biogen (BIIB) PT Lowered to $159 at Bernstein, Reflecting Lowered 2025 Revenue Estimate
Feb 13, 2025 08:28AM Biogen (BIIB) PT Lowered to $200 at TD Cowen as '2025 Guidance Reflects Declining MS Franchise'
Feb 13, 2025 08:08AM Biogen (BIIB) PT Lowered to $225 at RBC Capital
Feb 13, 2025 07:59AM Biogen (BIIB) PT Lowered to $210 at Truist Securities; 'Focus on Topline Growth/Pipeline'
Feb 13, 2025 07:39AM Biogen (BIIB) PT Lowered to $241 at H.C. Wainwright
Feb 13, 2025 07:00AM Biogen (BIIB) PT Lowered to $139 at BMO Capital; 'No Easy Answers to Get Back to Growth'
Feb 13, 2025 06:55AM Biogen (BIIB) PT Lowered to $224 at Scotiabank
Feb 12, 2025 07:07AM Biogen (BIIB) Tops Q4 EPS by 3c; offers outlook
Feb 12, 2025 06:30AM Royalty Pharma plc (RPRX) Announces R&D Funding Collaboration With Biogen
Feb 12, 2025 02:00AM Biogen (BIIB) Biogen Q4 earnings preview: here’s what to expect
Feb 11, 2025 10:43AM Biogen (BIIB) February 14 weekly option implied volatility into quarter results
Feb 11, 2025 04:44AM Bernstein SocGen Group Starts Biogen (BIIB) at Market Perform
Feb 5, 2025 09:18AM Biogen (BIIB) PT Lowered to $206 at Cantor Fitzgerald
Jan 31, 2025 06:40AM Biogen (BIIB) Issues Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
Jan 27, 2025 09:21AM Sage Therapeutics (SAGE) Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s (BIIB) Unsolicited Acquisition Proposal
Jan 27, 2025 09:21AM SAGE Therapeutics (SAGE) Explores Strategic Alternatives
Jan 26, 2025 06:54PM FDA Approves Eisai and Biogen's LEQEMBI IV Maintenance Dosing for Treatment of Early Alzheimer’s Disease
Jan 23, 2025 07:31AM Biogen (BIIB): FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
Jan 22, 2025 12:10PM Biogen (BIIB) makes cuts across its research unit, shifting focus to ‘external opportunities’ - endpoints
Jan 15, 2025 10:33AM Oppenheimer Reiterates Outperform Rating on Biogen (BIIB)
Jan 15, 2025 08:06AM Biogen (BIIB) Appoints Sean Godbout as Chief Accounting Officer & Global Corporate Controller
Jan 13, 2025 07:42AM SAGE Therapeutics (SAGE) Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen (BIIB) (earlier)
Jan 7, 2025 09:07AM Biogen (BIIB) PT Lowered to $231 as RBC Capital Sees 'Attractive Entry Point for Shares'
Jan 1, 2025 11:29PM Piper Sandler Downgrades Biogen (BIIB) to Neutral
Dec 30, 2024 06:31AM Halozyme (HALO) Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ with ENHANZE® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (nivolumab) Indications
Dec 20, 2024 04:08AM BMO Capital Downgrades Biogen (BIIB) to Market Perform
Dec 19, 2024 11:16AM RBC Capital's Game Changers: 'Disruptive Forces in Biotech'
Dec 16, 2024 04:49AM Stifel Downgrades Biogen (BIIB) to Hold
Dec 11, 2024 09:44AM Truist: 'Potential Impact of Trump's Nominees on Biopharma'
Dec 9, 2024 04:32AM Jefferies Downgrades Biogen (BIIB) to Hold
Nov 18, 2024 03:09PM Biogen (BIIB) call put ratio 2.4 calls to 1 put with focus on 1300 contracts of December 185 calls
Nov 18, 2024 08:47AM Needham Downgrades Biogen (BIIB) to Hold, 'Expert Checks Suggest Slow Leqembi Ramp; Limited 2025 Catalysts'
Nov 18, 2024 07:02AM Samsung Bioepis and Biogen (BIIB) Receive EU Approval for OPUVIZ
Nov 15, 2024 07:18AM Biogen (BIIB) PT Raised to $300 at Baird
View More Recent Stories View Older Stories